Keywords: AFP; alpha-fetoproteins; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ELISA; enzyme-linked immunosorbent assay; GGT; gamma glutaryl transpeptidase; HBeAg; hepatitis B e antigen; HBe ab; hepatitis B e antibody; HBsAg; hepatitis B surface
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Hepatitis B; Guidelines; Antiviral Therapy; Peginterferon alfa-2a; Entecavir; Tenofovir; Resistance; AFP; alpha-fetoprotein; ALT; alanine aminotransferase; anti-HBc; antibody to hepatitis B core antigen; anti-HBe; antibody to hepatitis B e antigen; anti-H
Keywords: ALT; alanine aminotransferase; CHBe-; HBeAg-negative chronic hepatitis B; CHBe+; HBeAg-positive chronic hepatitis B; CHD; chronic hepatitis D; CI; confidence interval; HBeAg; hepatitis B “e” antigen; HBsAg; hepatitis B surface antigen; HBV DNA; hepati
Keywords: FRAP; ferric reducing antioxidant power; FBS; fetal bovine serum; GAE; gallic acid equivalents; GSE; grape seed extract; HBeAg; hepatitis B “e” antigen; HBsAg; hepatitis B surface antigen; HCC; hepatocellular carcinoma; HBV; human hepatitis B; MAPK; m
Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure
Keywords: HBV; hepatitis B virus; ACLF; acute-on-chronic liver failure; LC; liver cirrhosis; CHB; chronic hepatitis B; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; GPR; gamma-glutamyl transpeptidase-to-platelet ratio; MELD; model for end-stage
miR-146 promotes HBV replication and expression by targeting ZEB2
Keywords: HBV; hepatitis B virus; HCC; hepatocellular carcinoma; ZEB2; Zinc finger E-box-binding homeobox 2; IFN-α; interferon-α; NA; nucleotide analogues; miRNAs; microRNAs; CHB; chronic hepatitis B; CHORDC1; cysteine- and histidine-rich domain containing 1; FBS
Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses
Keywords: Hepatitis B virus; Yeast-derived recombinant vaccine; Immunogenicity; Lymphocyte subsets; Vaccine failure; HBV; hepatitis B virus; HBIG; hepatitis B immunoglobulin; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; anti-HBc; antibodies aga
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study
Keywords: Early hepatocellular carcinoma; Microvascular invasion; HBeAg; Hepatectomy; Survival; HCC; hepatocellular carcinoma; TNM; Tumor-Node-Metastasis; BCLC; Barcelona clinic liver cancer; RFS; recurrence-free survival; OS; overall survival; ALT; alanine aminotr
Immunoprophylaxis Failure of Infants Born to Hepatitis B Carrier Mothers Following Routine Vaccination
Keywords: CI; confidence interval; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; IF; immunoprophylaxis failure;
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Keywords: PRR; Virus Immune Evasion; PAMP; Ex Vivo; CHB; chronic hepatitis B; CTRL; uninfected control; dsRNA; double-stranded RNA; HBcAg; HBV core protein; HBeAg; hepatitis B e antigen; HBsAg; HBV surface protein; HBV; hepatitis B virus; IFN; interferon; ISG; in
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Keywords: Viral Hepatitis; Immune Regulation; Neutralizing Antibody Response; Immunotherapy; ADCC; antibody-dependent cell-mediated cytotoxicity; anti-HBs; antibodies specific for hepatitis B surface antigen; ASC; antibody-secreting cell; CHB; chronic hepatitis B;
Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes
Keywords: CC; column chromatography; ECD; electronic circular dichroism; HBeAg; HBV e antigen; HBsAg; HBV surface antigen; HBV; hepatitis B virus; HPLC; high performance liquid chromatography; MPLC; medium pressure liquid chromatography; MS; mass spectrum; NMR; nuc
Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners
Keywords: HBV cccDNA; Transcription factor; Epigenetic regulation; ZHX2; Zinc finger and homeoboxes 2; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBcAg; hepatitis B core antigen;
Novel HBV recombinants between genotypes B and C in 3â²-terminal reverse transcriptase (RT) sequences are associated with enhanced viral DNA load, higher RT point mutation rates and place of birth among Chinese patients
Keywords: AA; amino acid; ADV; adefovir-dipivoxil; ALT; alanine aminotransferase; AST; aspartate aminotransferase; C; core; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; NUC; nucleos(t)ide analog
Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy
Keywords: Hepatitis B virus; Chronic hepatitis B; Hepadnaviridae; Vertical transmission; Viral life cycle; p22cr; 22-kDa core-related protein; anti-HBc; anti hepatitis B core protein antibodies; Alix; apoptosis linked gene II interacting protein X; ARD; arginine-ri
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection
Keywords: CAM; ER Stress Response; Assembly Inhibitor Core Protein; Replication; DAA; ALT; alanine aminotransferase; CAM; capsid assembly modulator; cccDNA; covalently closed circular DNA; ER; endoplasmatic reticulum; ETV; entecavir; h-Alb; human albumin; HAP; hete
Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients
Keywords: Hepatitis B virus core protein; Chronic hepatitis B; Deep sequencing; HBeAg status; Treatment response; HBV; hepatitis B virus; CHB; chronic hepatitis B; NUC; nucleos(t)ide analogues; peg-IFN; pegylated interferon; HBsAg; hepatitis B surface antigen; HBc;
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2â²-deoxy-2â²-fluoro- 4â²-azido nucleoside derivatives as potent anti-HBV agents
Keywords: 2â²-deoxy-2â²-β-fluoro-4â²-azido-β-d-arabinofuranosyl 1,2,3-triazole nucleoside; Anti-HBV activity; Nucleoside reverse transcriptase inhibitor (NRTI); Lamivudine-resistant HBV mutants; Viral DNA replication; HBV; hepatitis B virus; HCV; hepatitis C v
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
Keywords: Coinfection; Interferon-stimulated Gene; PRR; RIG-I; APOBEC; apolipoprotein B mRNA editing enzyme catalytic subunit; cccDNA; covalently closed circular DNA; CHB; chronic hepatitis B; circDNA; circular DNA; GFP-IRF3; green fluorescent protein-interferon
A novel mutation in TAP1 gene leading to MHC class I deficiency: Report of two cases and review of the literature
Keywords: Anti-HBc IgG; antibody against Hepatitis B core antigen; CVID; common variable immunodeficiency; ER; endoplasmic reticulum; HBeAg; Hepatitis B envelope antigen; HBsAg; Hepatitis B surface antigen; HBV; Hepatitis B virus; HLA; human leukocyte antigen; Ig;
The nucleotide changes within HBV core promoter/precore during the first 12Â weeks of nucleos(t)ide treatment might be associated with a better virological response
Keywords: ADV; adefovir dipivoxil; BCP; basic core promoter; CHB; chronic hepatitis B; CP; core promoter; EN II; enhancer II; HBeAg; hepatitis e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; LMV; lamivudine; Mut; mutation; NUC; nucleoside/nuc
miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines
Keywords: miR-101; FOXO1; HBV replication; HBsAg; HBeAg;
Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (â) mothers
Keywords: HBV; hepatitis B virus; HBsAg; hepatitis B virus surface antigen; HBeAg; hepatitis B virus e antigen; HepB; hepatitis B vaccine; HBIG; hepatitis B immunoglobulin; MTCT; mother-to-child transmission; anti-HBs; antibody to hepatitis B virus surface antigen;
Clinical response to long-term tenofovir monotherapy in Korean chronic hepatitis B patients
Keywords: Ab; antibody; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CCC; covalently closed circular; CHB; chronic hepatitis B; CVR; complete virologic response; HBeAg; hepatitis B e antigen; HCC; hepatocellular carcinoma; LC; liver cirrhosis; PV
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
Keywords: HBV; Hepatitis B virus; HCC; Hepatocellular carcinoma; CHB; Chronic hepatitis B; HBsAg; Hepatitis B surface antigen; HBeAg; Hepatitis B e antigen; TB; Total bilirubin; HCV; Hepatitis C virus; HIV; Human immunodeficiency virus; ETV; Entecavir; ADV; Adefovi
The Predictive Value of Baseline HBsAg Level and Early Response for HBsAg Loss in Patients with HBeAg-positive Chronic Hepatitis B during Pegylated Interferon Alpha-2a Treatment
Keywords: Chronic hepatitis B; HBsAg loss; HBeAg; Pegylated interferon alpha-2a;
T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
Keywords: OMT; oxymatrine; HBV; hepatitis B virus; ETV; entecavir; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; HBcAg; hepatitis B core antigen; IFN-γ; interferon-γ; TNF-α; tumor necrosis factor-α; HE; hematoxylin and eosin; ALT; alanine am
Novel non-canonical genetic rearrangements termed “complex structural variations” in HBV genome
Keywords: HBV; hepatitis B virus; HCC; hepatocellular carcinoma; SVs; structural variations; HBeAg; hepatitis B e antigen; WMHV; woolly monkey hepatitis virus; CURS; core upstream regulatory region; BCP; basic core promoter; HNF1; hepatocyte nuclear factor 1; Hepat
No. 342-Hepatitis B and Pregnancy
Keywords: Hepatitis B; antiviral therapy; breast-feeding; chronic hepatitis; immuno-prophylaxis; vertical transmission; viral load; pregnancy; ALT; alanine aminotransferase; anti-HBe; hepatitis B envelope antibody; anti-HBs; hepatitis B surface antibody; CHB; chron
Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes
Keywords: HBV; Hepatitis B Virus; HBsAg; Hepatits B Virus surface antigen; HBcAg; Hepatitis B Virus core antigen; HBeAg; Hepatitis B Virus e antigen; L/M/SHBs; large/middle/small Hepatitis B Virus surface protein; HBx; Hepatitis B Virus regulatory protein; HBV/X; H
Managing sharps injuries and other occupational exposures to HIV, HBV, and HCV in the dermatology office
Keywords: hepatitis B; hepatitis C; HIV; needlestick injuries; occupational exposures; anti-HBs; antibody to hepatitis B surface antigen; CDC; Centers for Disease Control and Prevention; HBeAg; hepatitis B e antigen; HBIG; hepatitis B immunoglobulin; HBsAg; hepatit
Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy
Keywords: ALT; Alanine aminotransferase; CHB; Chronic hepatitis B; CM; Conditioned medium; CR; Complete response; HBeAg; Hepatitis B e antigen; HBsAg; Hepatitis B surface antigen; HBV; Hepatitis B virus; HC; Healthy control; ICS; Intracellular cytokines staining; I
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Keywords: Therapy; Risk Factor; Coinfection; Prognostic Factor; CHC; chronic hepatitis C; DAA; direct-acting antiviral agent; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C v
Eradicating hepatitis B virus: The critical role of preventing perinatal transmission
Keywords: Chronic HBV infection; Eradication; Escape mutant; Hepatitis B immune globulin; Hepatitis B vaccine; Hepatitis B surface antigen; Mother-to-child transmission; Perinatal HBV infection; Prevention; HBV; hepatitis B virus; HBIG; hepatitis B immunoglobulins;
The Ca2+/CaMKK2 axis mediates the telbivudine induced upregulation of creatine kinase: Implications for mechanism of antiviral nucleoside analogs' side effect
Keywords: LdT; Telbivudine; HBV; hepatitis B virus; CHB; chronic Hepatitis B; CK; creatine kinase; HSKMCs; human skeletal muscle cells; SOD; superoxide dismutase; MDA; malondialdehyde; LPO; lipid peroxide; ROS; reactive oxygen species; CaMKK2; calmodulin-dependent
Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector
Keywords: Sulfamoylbenzamide; Antiviral agent; HBV; Capsid assembly effector; cccDNA; HBeAg;
Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer
Keywords: HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HBsAg; hepatitis B surface antigen; P; polymerase; HBeAg; hepatitis B e antigen; L, M, S; large middle and small envelope proteins; pcRNA; precore RNA; pgRNA; pregenomic RNA; PCR; polymerase chain rea
Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection
Keywords: Chronic hepatitis B; Antiviral therapy; IFN signaling pathway; STAT1; MX; Peg-IFN; pegylated interferon; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; NAs; nucleot(s)ide analogues; CHB; chronic hepatitis B; ETV; entecavir; ISGs; interf
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy
Keywords: Hepatitis B Virus Infection; HBV; Adiponutrin/Patatin-Like Phospholipase-3; Serum Transaminase; ALT; alanine aminotransferase; BMI; body mass index; CHB; chronic hepatitis B; CI; confidene interval; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface
Two-way molecular ligation for efficient conversion of monomeric hepatitis B virus DNA constructs into tandem dimers
Keywords: cccDNA; covalently closed circular DNA; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; pg RNA; pregenomic RNA; Hepatitis B virus; Covalently closed circular DNA; Tandem dimer; Prege
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon
Keywords: Hepatitis B treatment; PEG-IFN; HBV genotype; qHBsAg; HBeAg-negative; HBV; Hepatitis B virus; NA; nucleos(t)ide analogues; CHB; chronic hepatitis B; PEG-INF; pegylated interferon; HBsAg; hepatitis B surface antigen; ALT; alanine aminotransferase; HBeAg; h
Clinical challengeChronic hepatitis B and fatty liver: Issues in clinical management
Keywords: ALT; Alanine aminotransferase; CHB; chronic hepatitis B; AASLD; American association for study of liver disease; APASL; Asia-pacific association for study of liver; EASL; European association for study of liver; HCC; hepatocellular carcinoma; HBeAg; hepat
Re-recognizing serological change patterns and antiviral therapy opportunity of patients with acute hepatitis B through highly sensitive detection technology
Keywords: AHB; Acute hepatitis B; HBV; Hepatitis B virus; HBsAg; Hepatitis B surface antigen; PCR; Polymerase chain reaction; HBV-Ms; Serological markers of HBV; ECLIA; Electrochemiluminescence immunoassay; anti-HBc IgM; Immunoglobulin M antibody to HBV core; HBeAg
Impact of HBeAg on the maturation and function of dendritic cells
Keywords: HBeAg; Regulatory dendritic cells; Cell differentiation; Immune regulation; Chronic hepatitis B
Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2
Keywords: AA; amino acid; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HIV; human immunodeficiency virus; HSPGs; highly sulfated heparan sulfate proteoglycans; LdT; telb
Hepatitis B virus antigens impair NK cell function
Keywords: HBV; Hepatitis B virus; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; poly (I:C); polyinosinic-polycytidylic acid; Natural killer cell; HBsAg; HBeAg; STAT1; NF-κB; p38 MAPK;
Clinical Significance of Quantitative HBsAg Titres and its Correlation With HBV DNA Levels in the Natural History of Hepatitis B Virus Infection
Keywords: HBeAg; hepatitis B early antigen; HBV; hepatitis B virus; IT; immune tolerance phase; IC; immune clearance phase; LR; low-replicative phase; hepatitis B virus; HBsAg; HBeAg; quantitative HBsAg; HBV DNA quantitative;
Research ArticleRandomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Keywords: AE; adverse event; ALT; alanine aminotransferase; Anti-HBs; hepatitis B surface antibody; AST; aspartate aminotransferase; CI; confidence interval; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HBx; hepatitis B
Research ArticleRestoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy
Keywords: HBV; hepatitis B virus; HBsAg; hepatitis B surface antigen; CHB; chronic hepatitis B; HBeAg; hepatitis B e antigen; PegIFN; peginterferon alpha 2a; NUC; nucleot(s)ide analogues; HLA; human leucocyte antigen; ALT; alanine aminotransferase; LVL; low viral l